Our Services
We provide a comprehensive array of financial services to a diverse range of corporate clients, institutional investors, and high net worth investors.
Investment Banking
Equity Research
Capital Markets
Merchant Capital
Wealth Management
Prime Brokerage
Recent
Transactions
Over 180 financings and $23.5 Billion in aggregate as Lead, Joint, or Co-Manager in 2021
$14.7 Million
Initial Public Offering
// Lead Book-Running Manager
May 2022
$75.0 Million
Initial Public Offering
// Sole Book-Running Manager
May 2022
$185.0 Million
Initial Public Offering
// Sole Book-Running Manager
May 2022
$294.1 Million
Business Combination
// Sole Financial Advisor to VCV Digital Technology
May 2022
$5.0 Million
PIPE
// Sole Placement Agent
April 2022
$9.4 Million
Initial Public Offering
// Sole Book-Running Manager
April 2022
$30.0 Million
Follow-On Offering
// Sole Book-Running Manager
April 2022
$45.0 Million
CMPO
// Co-Lead Manager
April 2022
Business Combination
// Financial Advisor to SeaStar Medical
April 2022
$5.0 Million
PIPE
// Sole Placement Agent
April 2022
$4.3 Million
Follow-On Offering
// Sole Book-Running Manager
April 2022
![Maxim_Merchant-Capital_logo-01[1]](https://www.maximgrp.com/wp-content/uploads/2020/02/Maxim_Merchant-Capital_logo-011.svg "Maxim_Merchant-Capital_logo-01[1]"){kind=logo}
Merchant Capital
Maxim Merchant Capital’s skilled specialists have significant experience in raising private capital for both late-stage and early-stage private and public companies across a range of industries; predominantly in life sciences/biotechnology. Within the biotech sector, we look for companies that address significant unmet needs and have a clear regulatory path.
